150 likes | 744 Views
Trends in age-specific HIV prevalence rate among antenatal women 1992-2009, Botswana sentinel surveillance. Incidence and key populations. Incidence is becoming important measure for tracking epidemic
E N D
Trends in age-specific HIV prevalence rate among antenatal women 1992-2009, Botswana sentinel surveillance
Incidence and key populations • Incidence is becoming important measure for tracking epidemic • 2008, BAIS III made an effort to measure incidence and data is still being analysed with expert support • Lack of HIV data on key populations • Know Your Epidemic Study being finalized will assist to learn more about epi and where new infections are coming from
Key drivers/risk factors multiple and concurrent partnerships by men and women with low consistent condom use and in the context of low levels of male circumcision”, and: • male attitudes and behaviours • inter-generational sex /age-disparate sex • sexual and gender based violence • stigma, denial, lack of openness • untreated viral STIs • Lack of/inadequate male involvement Underlying context - gender and socio-economic inequalities, mobility, and other structural factors
HIV Testing In Botswana Source: RHT, TEBELOPELE, BOCAIP AND BOFWA QUARTERLY M&E REPORTS
Botswana NSF II (2010-2016) • Accelerate Prevention to reduce HIV incidence by at least 50% by 2016: Country wide campaign against MCP launched mid 2009, scale up MC to cover > 400,000 by 2016, move towards virtual elimination of MTCT, strengthen social and community mobilization and empowerment for prevention ownership and effective engagement to drive the agenda. Combination prevention interventions • Strengthen institutional and community capacity including improvement of enabling environment to access services. • Improve management of strategic information • Scale up treatment , care and support including TB/HIV Focusing on quality improvements, efficiencies, effectiveness & sustainability of programmes/interventions ESA reduction in incidence will avert 2.25 mil new infections, 08-15 and cumulative Rx costs averted, 11.5 billion dollars
Resources Reduced/flat funding will • Affect prioritization of prevention (MC, MCP interventions etc) • Hamper efforts to increase Rx coverage and negate the gains made towards universal access and quality • Lead to an increase in MTCT and pediatric AIDS. • Compromise ability to strengthen institutional and community capacity • Affect operations research